FDA Inspection 1315028 — Eduardo E. Rodriguez-Araya, MD
The FDA completed an inspection of Eduardo E. Rodriguez-Araya, MD on May 1, 2026 in New Orleans, LA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 1, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New Orleans, LA (United States)
Additional Details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 7378 | 21 CFR 50.27(a) | Copy of consent form not provided |
| 7560 | 21 CFR 312.60 | FD-1572, protocol compliance |